Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Imipenem Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Sterile Type
  • 1.3.3 Non-sterile Type
• 1.4 Market Segment by Application
  • 1.4.1 Global Imipenem Market Share by Application (2019-2025)
  • 1.4.2 Injection
  • 1.4.3 Other
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Imipenem Market Size
  • 2.1.1 Global Imipenem Revenue 2014-2025
  • 2.1.2 Global Imipenem Sales 2014-2025
• 2.2 Imipenem Growth Rate by Regions
  • 2.2.1 Global Imipenem Sales by Regions 2014-2019
  • 2.2.2 Global Imipenem Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Imipenem Sales by Manufacturers
  • 3.1.1 Imipenem Sales by Manufacturers 2014-2019
  • 3.1.2 Imipenem Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Imipenem Revenue by Manufacturers (2014-2019)
  • 3.2.2 Imipenem Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Imipenem Market Concentration Ratio (CR5 and HHI)
• 3.3 Imipenem Price by Manufacturers
• 3.4 Key Manufacturers Imipenem Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Imipenem Market
• 3.6 Key Manufacturers Imipenem Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Sterile Type Sales and Revenue (2014-2019)
  • 4.1.2 Non-sterile Type Sales and Revenue (2014-2019)
• 4.2 Global Imipenem Sales Market Share by Type
• 4.3 Global Imipenem Revenue Market Share by Type
• 4.4 Imipenem Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Imipenem Sales by Application

6 United States

• 6.1 United States Imipenem Breakdown Data by Company
• 6.2 United States Imipenem Breakdown Data by Type
• 6.3 United States Imipenem Breakdown Data by Application

7 European Union

• 7.1 European Union Imipenem Breakdown Data by Company
• 7.2 European Union Imipenem Breakdown Data by Type
• 7.3 European Union Imipenem Breakdown Data by Application

8 China

• 8.1 China Imipenem Breakdown Data by Company
• 8.2 China Imipenem Breakdown Data by Type
• 8.3 China Imipenem Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Imipenem Breakdown Data by Company
• 9.2 Rest of World Imipenem Breakdown Data by Type
• 9.3 Rest of World Imipenem Breakdown Data by Application
• 9.4 Rest of World Imipenem Breakdown Data by Countries
  • 9.4.1 Rest of World Imipenem Sales by Countries
  • 9.4.2 Rest of World Imipenem Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Savior Lifetec
  • 10.1.1 Savior Lifetec Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Imipenem
  • 10.1.4 Imipenem Product Introduction
  • 10.1.5 Savior Lifetec Recent Development
• 10.2 Sun Pharmaceutical Industries
  • 10.2.1 Sun Pharmaceutical Industries Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Imipenem
  • 10.2.4 Imipenem Product Introduction
  • 10.2.5 Sun Pharmaceutical Industries Recent Development
• 10.3 Kopran
  • 10.3.1 Kopran Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Imipenem
  • 10.3.4 Imipenem Product Introduction
  • 10.3.5 Kopran Recent Development
• 10.4 HISUN Pharmaceutical
  • 10.4.1 HISUN Pharmaceutical Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Imipenem
  • 10.4.4 Imipenem Product Introduction
  • 10.4.5 HISUN Pharmaceutical Recent Development
• 10.5 Haibin Pharmaceutical
  • 10.5.1 Haibin Pharmaceutical Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Imipenem
  • 10.5.4 Imipenem Product Introduction
  • 10.5.5 Haibin Pharmaceutical Recent Development
• 10.6 United Lab
  • 10.6.1 United Lab Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Imipenem
  • 10.6.4 Imipenem Product Introduction
  • 10.6.5 United Lab Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Imipenem Sales Channels
  • 11.2.2 Imipenem Distributors
• 11.3 Imipenem Customers

12 Market Forecast

• 12.1 Global Imipenem Sales and Revenue Forecast 2019-2025
• 12.2 Global Imipenem Sales Forecast by Type
• 12.3 Global Imipenem Sales Forecast by Application
• 12.4 Imipenem Forecast by Regions
  • 12.4.1 Global Imipenem Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Imipenem Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Imipenem is a broad spectrum carbapenem antibiotic which is used for severe bacterial infections.
In 2019, the market size of Imipenem is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Imipenem.

This report studies the global market size of Imipenem, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Imipenem sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Savior Lifetec
Sun Pharmaceutical Industries
Kopran
HISUN Pharmaceutical
Haibin Pharmaceutical
United Lab
...

Market Segment by Product Type
Sterile Type
Non-sterile Type

Market Segment by Application
Injection
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Imipenem status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Imipenem manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Imipenem are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025